Vitro Biopharma, Inc. (VTRO)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Vitro Biopharma, Inc. Stock (VTRO) Company Profile

Vitro Biopharma, Inc.

Healthcare (1140)

Biotechnology (637)

(720) 859-4120

4621 TECHNOLOGY DRIVE, GOLDEN

VTRO's Discussions on Twitter

VTRO を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
VTRO Vitro Biopharma, Inc.	0.00	0	1.65M	-5.91M	-3.03M	-0.1707
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Vitro Biopharma, Inc. (VTRO) 最新ニュース

Vitro Biopharma, Inc. (VTRO) 財務データ

Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma, Inc. Stock (VTRO) Company Profile

VTRO を他の銘柄と比較する

Vitro Biopharma, Inc. (VTRO) 最新ニュース

Best Biotech Stocks to Buy in 2025 - The Motley Fool

What Stem Cell Clinics Do You Trust? - BioInformant

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - The Manila Times

Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative - ACCESS Newswire

Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director - ACCESS Newswire

10 cultured meat companies driving sustainable food in 2025 - Labiotech.eu

Vitro Biopharma's AlloRx Stem Cell TherapyFeatured in New York Times Article on Health Secretary Kennedy's, Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire

Vitro Biopharma's AlloRx Stem Cell Therapy Featured in New York Times Article on Health Secretary Kennedy's Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire

GC Genome plans $30M IPO to diversify genomic products, suppliers - BioWorld MedTech

Vitro Biopharma, Inc. announced a financing transaction - marketscreener.com

Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat COVID-19 - ACCESS Newswire

Vitro Biopharma’s CEO Elaborates on Merger-Driven Growth Acceleration in an Interview with the Wall Street Analyst - ACCESS Newswire

Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - CRISPR Medicine News

Press Release Distribution & PR Platform - ACCESS Newswire

Contrasting Vitro Diagnostics (OTCMKTS:VODG) and Vaxcyte (NASDAQ:PCVX) - Defense World

Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies - BioSpace

Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World

Dealmaking Quarterly Statistics, Q2 2022 - insights.citeline.com

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - Yahoo Finance

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases - Labiotech.eu

Dealmaking Quarterly Statistics, Q4 2024 - insights.citeline.com

Financing Quarterly Statistics, Q4 2024 - insights.citeline.com

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire

Achieving success in biopharma with recombinant antibody technology - News-Medical

Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - Stock Titan

The In Vitro Activity of Rezafungin Against Uncommon Species of CandidaWinkler2024Mycoses - Wiley Online Library

In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace

Swiss biotech going strong in 2024: 18 companies to put on your radar - Labiotech.eu

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire

Vitro Biopharma, Inc. announced that it has received $1 million in funding - MarketScreener

Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights

Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa - PR Newswire

Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity - ACS Publications

(PDF) Comprehensive Review on Drug Discovery and Development Process - researchgate.net

A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive

New In Vitro Data Showing Matinas BioPharma’s LNC Platform - GlobeNewswire

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - BioSpace

FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive

21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector - Built In

ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data - ScienceDirect.com

Women’s health company Obseva to wind down, lay off staff - BioPharma Dive

Anima Biotech’s IPF candidate disrupts transformation of fibroblasts into fully differentiated myofibroblasts - BioWorld MedTech

Vitro Biopharma adds Crown Resorts legal, compliance chief to board - Compliance Week

Vitro Biopharma Announces Thomas Ohrt New Chief Financial Officer - MarketScreener

Vitro Biopharma, Inc. Announces Chief Financial Officer Changes - MarketScreener

The TIM Company Appoints Biotech Veteran Dr. Behzad Mahdavi as Transformative CEO and Board Member - PR Newswire

Swiss investment firm denies acquisition bid for Boryung Biopharma - koreabiomed.com

UB-VV200 particles plus TumorTags control tumor growth in vivo - BioWorld MedTech

Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development - PR Newswire

In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research - Yahoo Finance

Vitro Biopharma, Inc. (VTRO) 財務データ

収益

当期純利益

現金流量

EPS

VTROに似た銘柄